CMMB Chemomab Therapeutics Ltd.
Nasdaq · SEC CIK 1534248 · EDGAR
- Bought, last 12 months
- -$20.2K 1 purchases by 1 insiders
- Sold, last 12 months
- $6,516 1 sales by 1 insiders
- Filings on record
- 27 since 2021-12-08, latest 2026-09-01 10:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Cohen Neil Harris | Dir | — | $6,516 |
| Mor George Adi | CEO, Dir | -$20.2K | — |
Transactions 18
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-09-01 10:05 | 2026-08-27+ | CMMB | Cohen Neil Harris | Dir | S - Sale | $2.83 | -2,304 | 33.0K | -7% | -$6,516 |
| M | 2026-06-01 07:33 | 2026-05-29 | CMMB | Mor George Adi | CEO, Dir | P - Purchase | $2.07 | -9,804 | 139.1K | -7% | -$20.2K |
| M | 2026-06-01 07:33 | 2026-05-29 | CMMB | Mor George Adi | CEO, Dir | J - Other | — | -50.5K | 18.8K | -73% | — |
| DI | 2023-01-05 | 2023-01-03 | CMMB | Mor George Adi | CSO, Dir | S - Sale | $5.03 | -6,100 | 251.1K | -2% | -$30.7K |
| D | 2023-01-05 | 2023-01-03 | CMMB | Mor George Adi | CSO, Dir | S - Sale | $5.03 | -7,700 | 317.1K | -2% | -$38.7K |
| MI | 2023-01-05 | 2023-01-03 | CMMB | OrbiMed Israel BioFund GP Limited Partnership | 10% | S - Sale | $3.58 | -336.9K | 2.31M | -13% | -$1.21M |
| D | 2022-11-18 | 2022-11-16 | CMMB | Cohen Neil Harris | Dir | S - Sale | $2.00 | -2,409 | 10.0K | -19% | -$4,818 |
| D | 2022-11-17 | 2022-11-16 | CMMB | Mor George Adi | CSO, Dir | S - Sale | $2.08 | -324.8K | 324.8K | -50% | -$675.5K |
| DI | 2022-11-17 | 2022-11-16 | CMMB | Mor George Adi | CSO, Dir | S - Sale | $2.08 | -257.2K | 257.2K | -50% | -$535.1K |
| DM | 2022-06-21 | 2022-03-16 | CMMB | Marvin Donald | CFO, COO, Executive VP | P - Purchase | $3.27 | +500 | 2,000 | +33% | +$1,638 |
| DM | 2022-05-25 | 2022-05-24 | CMMB | Maryles Joel Michael | Dir | P - Purchase | $2.88 | +433 | 1,433 | +43% | +$1,247 |
| D | 2022-05-19 | 2022-05-18 | CMMB | Cohen Neil Harris | Dir | P - Purchase | $3.19 | +2,000 | 12.4K | +19% | +$6,380 |
| DM | 2022-03-21 | 2022-03-18 | CMMB | Maryles Joel Michael | Dir | P - Purchase | $4.34 | +1,000 | 500 | New | +$4,340 |
| DM | 2022-03-21 | 2022-03-14 | CMMB | Marvin Donald | CFO, COO, Executive VP | P - Purchase | $4.04 | +1,250 | 500 | New | +$5,045 |
| DM | 2022-03-15 | 2022-03-14 | CMMB | Pfost Dale R | CEO, Dir | P - Purchase | $3.98 | +2,500 | 1,800 | New | +$9,943 |
| DM | 2022-03-15 | 2022-03-14 | CMMB | Cohen Neil Harris | Dir | P - Purchase | $4.35 | +6,000 | 6,409 | +1,467% | +$26.1K |
| D | 2022-03-14 | 2022-03-11 | CMMB | Darvish Nissim | Dir | P - Purchase | $4.28 | +1,200 | 1,200 | New | +$5,136 |
| 2021-12-08 | 2021-12-06 | CMMB | Cohen Neil Harris | Dir | P - Purchase | $7.43 | +2,000 | 4,409 | +83% | +$14.9K |
Purchase Sale Sale after option exercise All abbreviations